Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases

Trial Profile

Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Corticosteroids
  • Indications Brain metastases
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 03 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 25 Mar 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Apr 2020 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top